Cases(n=6665) | Controls (n=26660) | |
---|---|---|
Sex (% men) | 3 240 (48.6%) | 12 957 (48.6%) |
Age (years) | 70.2±14.1 | 70.2±14.1 |
No of years of follow-up (years) | 4.2±4.0 | 4.2±4.0 |
In the previous year: | ||
Hospitalisation for COPD and/or asthma, % | 31.0 | 9.0 |
Number of hospitalisations | 1.1±1.4 | 0.3±0.8 |
Drugs possibly linked to ILD | 5.7±19.7 | 5.2±20.1 |
Antibiotics | 1.2±2.2 | 0.7±1.2 |
Respiratory drugs | 8.3±14.8 | 5.5±12.9 |
Inhaled corticosteroids | 3.8±9.3 | 2.0±7.1 |
Oral corticosteroids | 2.4±10.5 | 0.6±5.4 |
Cardiac drugs. % | 57.1 | 52.6 |
Antidepressant drugs, % | 17.1 | 14.8 |
NSAIDs, % | 35.3 | 33.8 |
Narcotics, % | 7.2 | 4.6 |
Antirheumatic drugs, % | 4.1 | 0.7 |
Other drugs, % | 17.0 | 1.0 |
Results given either as percentage or mean±SD.
ILD, interstitial lung disease; NSAID, non-steroidal anti-inflammatory drug.